Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /500422

Transchem Ltd.

500422 (TRANSCHEM)

• BSE: 500422 • Delayed

164.95INR 1%

1.73 USD

As of 13 June 2026, Transchem Ltd. has a market cap of $21.17M USD, ranking #36715 globally and #2601 in India. It ranks #3297 in the Healthcare sector, and #200 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

36715

Country Rank

2601

Sector Rank

3297

Industry Rank

200

Key Stats

Market Cap

$21.17MUSD

2.02B INR

Enterprise Value

$21.08MUSD

2.01B INR

Revenue (TTM)

$254.23KUSD

24.24M INR

EBITDA (TTM)

-$295.55KUSD

-28.19M INR

Net Income (TTM)

$307.43KUSD

29.32M INR

EBITDA Margin

-116%

Profit Margin

121%

PE Ratio

68.8

PS Ratio

83.3

PB Ratio

2.5

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mahesh Rananavre open_in_new

Employees

Founded

1976

Website

transchem.net open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1%	-8.5%	1.4%	1.9%	121%	-11%	320%	674%	681%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	500422 (TRANSCHEM) Transchem Ltd ISIN: INE019B01010 Shares Out.: Shares Outstanding: 12.24M¹ TV: TradingView: BSE: TRANSCHEM SA: Stock Analysis: BOM: 500422 YF: Yahoo Finance: 500422.BO GF: Google Finance: BOM: 500422 BA: Barron's: 500422 MS: Morningstar: XBOM: 500422	164.95 INR	TV: TradingView: BSE: TRANSCHEM SA: Stock Analysis: BOM: 500422 YF: Yahoo Finance: 500422.BO GF: Google Finance: BOM: 500422 BA: Barron's: 500422 MS: Morningstar: XBOM: 500422

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Transchem Ltd.

Transchem Limited does not have significant operations. Previously, it was engaged in the growing and processing of mushrooms. The company was incorporated in 1976 and is based in Thane, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)

Name	Market Cap (USD) diff.	PE	Country
Cipla Ltd. NSE: CIPLA	$11.16B 1.06T INR 53K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.04B 1.05T INR 52K%	22.7	India
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.46B 807.02B INR 40K%	23.1	India
Cohance Lifesciences Ltd. NSE: SUVENPHAR	$1.88B 178.87B INR 9K%	199.0	India
Granules India Ltd. NSE: GRANULES	$1.83B 174.85B INR 9K%	32.1	India
Viyash Scientific Ltd. NSE: SEQUENT	$948.78M 90.48B INR 4K%	92.7	India

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$36.75B 108.92B ILS 173K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 140K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.84B 107.34B CNY 75K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.09B 61.6B CNY 43K%	80.6	China
ABIVAX Société Anonyme EPA: ABVX	$8.74B 7.57B EUR 41K%	-	France
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.21B 35.33B CNY 25K%	20.0	China

chevron_leftBack